Jefferies Initiates Coverage On Q32 Bio with Buy Rating, Announces Price Target of $29

Benzinga Newsdesk www.benzinga.com Neutral 59.3%

Neg 0% Neu 59.3% Pos 0%

Jefferies analyst Maury Raycroft initiates coverage on Q32 Bio (NASDAQ:QTTB) with a Buy rating and announces Price Target of $29.